Glenview Trust’s Congress SMid Growth ETF CSMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.2M Buy
1,212,165
+216,017
+22% +$7.13M 0.58% 39
2025
Q4
$31.5M Buy
996,148
+58,000
+6% +$1.89M 0.49% 43
2025
Q3
$31.2M Buy
938,148
+36,901
+4% +$1.19M 0.5% 39
2025
Q2
$28.1M Buy
901,247
+141,474
+19% +$4.12M 0.49% 45
2025
Q1
$21M Buy
759,773
+117,561
+18% +$3.49M 0.41% 57
2024
Q4
$19.2M Buy
+642,212
New +$19.6M 0.36% 63

Other funds holding CSMD

Glenview Trust's CSMD Position: Q1 2026 in Review

Glenview Trust increased its Congress SMid Growth ETF (CSMD) stake by 22% in Q1 2026, buying an estimated $7.13M and bringing the position to 1,212,165 shares worth $37.2M. The position accounts for 0.58% of the portfolio, ranked #39.

Glenview Trust first reported a position in CSMD in Q4 2024 and has held it in 6 quarters since. 37 funds tracked by Wall St. Rank hold CSMD as of Q1 2026.

  • Glenview Trust held 1,212,165 shares of Congress SMid Growth ETF worth $37.2M as of Q1 2026.
  • Glenview Trust bought 216,017 Congress SMid Growth ETF shares in Q1 2026, an estimated $7.13M.
  • Congress SMid Growth ETF made up 0.58% of Glenview Trust's portfolio in Q1 2026, its #39 holding.
  • Glenview Trust first reported a position in Congress SMid Growth ETF in Q4 2024 and has held it in 6 quarters since.
  • 37 funds tracked by Wall St. Rank held Congress SMid Growth ETF as of Q1 2026.

Based on Glenview Trust's 13F filing for Q1 2026, filed 8 May 2026.